Mascoma Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27
Closed -$1.85K 471
2024
Q2
$1.85K Hold
27
﹤0.01% 465
2024
Q1
$1.45K Hold
27
﹤0.01% 431
2023
Q4
$1.44K Hold
27
﹤0.01% 445
2023
Q3
$1.34K Hold
27
﹤0.01% 474
2023
Q2
$1.53K Hold
27
﹤0.01% 452
2023
Q1
$1.57K Hold
27
﹤0.01% 550
2022
Q4
$2K Buy
+27
New +$1.84K ﹤0.01% 565

Other funds holding GMED

Mascoma Wealth Management's GMED Position: Q3 2024 in Review

Mascoma Wealth Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 27 shares — an estimated $1.85K sold.

Mascoma Wealth Management first reported a position in GMED in Q4 2022 and held it in 7 quarters. The position peaked at $2K in Q4 2022. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Mascoma Wealth Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Mascoma Wealth Management sold 27 Globus Medical shares in Q3 2024, an estimated $1.85K.
  • Mascoma Wealth Management first reported a position in Globus Medical in Q4 2022 and held it in 7 quarters.
  • Mascoma Wealth Management's Globus Medical position peaked at $2K in Q4 2022.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Mascoma Wealth Management's 13F filing for Q3 2024, filed 5 Nov 2024.